Nipah Virus: A Neurotropic Zoonosis—From Molecular Biology to Clinical Manifestations and Translational Advances
Viruses · 01.09.2026 · 18 (9) · 958
DOI: 10.3390/v18090958 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 01.09.2026. Verfasst von Vignesh Mariappan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of …. Hauptthemen laut MEDLINE: Nipah Virus, Henipavirus Infections, Zoonoses. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural Research Program of the National Institutes of Health.
Abstract (Originalsprache)
Nipah virus (NiV) is a single-stranded negative-sense RNA virus of the genus Henipavirus, family Paramyxoviridae. The World Health Organization has declared NiV a priority pathogen with a great public health risk due to its epidemic potential and lack of sufficient countermeasures. In humans, the virus causes Nipah viral disease (NVD), characterized by acute respiratory failure and/or encephalitis. Long-term assessments of NVD survivors have revealed persistent neurological dysfunction, including encephalopathy, cerebral atrophy, hyperintensities, ocular motor palsies, and dystonia. The entry of NiV into the central nervous system (CNS) is one of the critical and less studied aspects of its pathogenesis. NiV rapidly targets the olfactory epithelial cells in the nasal turbinate and subsequently infects neurons, allowing its spread into the CNS via axonal transport. In addition, infection of immature dendritic cells has been associated with severe CNS disease, supporting a potential role of hematogenous dissemination in neuroinvasion. Overall, understanding the molecular mechanism and the role of host factors in NiV neuropathogenesis is crucial for developing effective strategies to combat NVD. The present review delves into the neuropathogenic mechanism and immunobiology of NiV infection, as well as advancements in therapeutic modalities and vaccines against NVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Virology, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rocky Mountain Laboratories (RML), Hamilton, MT 59840, U…
- Laboratory of Viral Zoonosis, Division of Intramural Research (DIR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Integrated Research Facility (IRF), Frederick, MD…
ORCID-Profile: Vignesh Mariappan, Heinz Feldmann
Förderung
- Intramural Research Program of the National Institutes of Health
Zitieren
APA
Mariappan, V., & Feldmann, H. (2026). Nipah Virus: A Neurotropic Zoonosis—From Molecular Biology to Clinical Manifestations and Translational Advances. Viruses, 18(9), 958. https://doi.org/10.3390/v18090958
Vancouver
Mariappan V, Feldmann H. Nipah Virus: A Neurotropic Zoonosis—From Molecular Biology to Clinical Manifestations and Translational Advances. Viruses. 2026;18(9):958. doi:10.3390/v18090958
BibTeX
@article{Mariappan2026,
author = {Mariappan, Vignesh and Feldmann, Heinz},
title = {Nipah Virus: A Neurotropic Zoonosis—From Molecular Biology to Clinical Manifestations and Translational Advances},
journal = {Viruses},
year = {2026},
volume = {18},
number = {9},
pages = {958},
doi = {10.3390/v18090958}
}
EUVIMED